CTIM-27. AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACCINATION IMPROVES SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA: SURVIVAL RESULTS FROM A PHASE 3 TRIAL

Authors: Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian Campian, John Trusheim, Fabio Iwamoto, David Tran, George Anstass, Charles Cobbs, Jason Heth, Michael Salacz, Stacy D'Andre, Robert Aiken, Yaron Moshel, JooYeon Nam, Clement Pillainayagam, Stephanie Wagner, Kevin Walter, Rekha Chaudary, Samuel Goldlust, Ian Lee, Daniela Bota, Heinrich Elinzano, Jai Grewal, Kevin Lillehei, Tom Mikkelsen, Tobias Walbert, Steve Abram, Andrew Brenner, Matthew Ewend, Simon Khagi, Darren Lovick, Jana Portnow, Lyndon Kim, William Loudon, Nina Martinez, Reid Thompson, David Avigan, Karen Fink, Francois Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott M Lindhorst, Jose Lutzky, Hans-Joerg Meisel, Minou Nadji-Ohl, Lhagva Sanchin, Andrew Sloan, Marnix Bosch

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.259

Source: Full article


Abstract

Abstract